Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 0.929% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) O=C(O)c1ccc2c(=O)n(-c3ccccc3)c(=S)[nH]c2c1
b) CC(OC(=O)C1CCCCC1)C(=O)Nc1ccc(S(N)(=O)=O)cc1
c) Cc1nnc2sc(SCC(=O)N3CCC(C)CC3)nn2c1=O
Answer: c. Cc1nnc2sc(SCC(=O)N3CCC(C)CC3)nn2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nnc2sc(SCC(=O)N3CCC(C)CC3)nn2c1=O
Cc1nnc2sc(SCC(=O)N3CCC(C)CC3)nn2c1=O
3-methyl-7-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]sulfanyl-[1,3,4]thiadiazolo[2,3-c][1,2,4]triazin-4-one